The reagent kit is used in the examination of patients diagnosed with colorectal cancer to determine indications for targeted therapy.
The reagent kit is used in the examination of patients diagnosed with colorectal cancer to determine indications for targeted therapy.
The reagent kit is used in the examination of patients diagnosed with non-small cell lung cancer (NSCLC) to determine indications for targeted therapy with EGFR tyrosine kinase inhibitors and monitor response to them.
The reagent kit is used in the examination of patients diagnosed with non-small cell lung cancer (NSCLC) to determine indications for targeted therapy with EGFR tyrosine kinase inhibitors and monitor response to them.
The testing kit is used when examining patients diagnosed with the metastatic melanoma stage III-IV in order to determine if they have indications for targeted therapy.
The gene expression kit is designed to detect 16 somatic mutations in the BRCA1 and BRCA2 genes and is used in the diagnosis of hereditary forms of breast, ovarian, pancreatic, and stomach cancer. The test allows predicting the course of the disease and determining an effective treatment strategy with both targeted medication and various chemotherapy programs.